Cabaletta Bio Reveals CABA-201's Positive Clinical Safety And Efficacy Data
Cabaletta Bio, Inc. (CABA), a clinical-stage biotechnology company focused on autoimmune diseases, announced Monday new and updated ...
Cabaletta Bio Presents Positive Clinical Safety and Efficacy Data on CABA-201 at ACR Convergence 2024
CABA-201 safety profile suggests favorable risk-benefit with no CRS or ICANS in the majority of patients; low-grade CRS in three of eight ...
NewsX1h
Rahul Gandhi Lists Congress Key Plans For Maharashtra, Takes A Jibe At BJP’s Slogan, Says ‘Adani Is Fully Supported By PM Modi’, WATCH
Support for Women: Direct financial assistance of ₹3,000 monthly into women’s bank accounts and free ... health insurance ...
Insight News10h
Present Practice: Art in times of collapse
While there are many forms of art beyond drawing in the show — including painting, sculpture, mixed media work, and textiles, ...
Vehicles should better protect against pedestrian head injuries, NHTSA says
The number of pedestrian deaths has risen substantially in the last decade. A proposed vehicle rule aims to reduce pedestrian ...
The New York Times18h
New York Times - Top Stories
Biden Allows Ukraine to Strike Russia With Long-Range U.S. Missiles President Biden for the first time authorized the use of a system known as ATACMS to help defend Ukraine’s forces in the Kursk ...